Solid Biosciences INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Perceptive Advisors LLC and its affiliates have disclosed a beneficial ownership of 11.2% of Solid Biosciences Inc. common stock, holding over 12 million shares and pre-funded warrants.
NASDAQ
RA Capital Management has increased its beneficial ownership in Solid Biosciences Inc. through recent open market and ATM offering purchases.
NASDAQ
RA Capital Management and its affiliates increased their beneficial ownership in Solid Biosciences Inc. to 9.9% through recent open market purchases totaling over $23.7 million.
NASDAQ
RA Capital Management and its affiliates have increased their beneficial ownership in Solid Biosciences Inc. to 9.9% through recent open market purchases.
NASDAQ
SCHEDULE 13D/A: Bain Capital Entities Increase Stake in Solid Biosciences Following $200 Million Public Offering
Bain Capital-affiliated entities have significantly increased their beneficial ownership in Solid Biosciences Inc. to 9.99% following the company's recent $200 million public offering of common stock and pre-funded warrants.
NASDAQ
SCHEDULE 13D/A: RA Capital Increases Stake in Solid Biosciences to 9.9% Through Pre-Funded Warrant Purchase
RA Capital Management and its affiliates have increased their beneficial ownership in Solid Biosciences Inc. to 9.9% following the purchase of pre-funded warrants for approximately $15 million.
NASDAQ
SCHEDULE 13D/A: Perceptive Advisors Increases Stake in Solid Biosciences to 15.6% Following $20.2 Million Share Acquisition
Perceptive Advisors LLC and its affiliates have significantly increased their beneficial ownership in Solid Biosciences Inc. to 15.6% of outstanding common stock, acquiring 5 million shares for $20.2 million in a recent underwritten offering.